X/LinkedIn/WFH/HematoOnkologia.PL/Luskin Orthopaedic Institute for Children/MedStar Health/SickKids
Aug 9, 2025, 15:03
Safety Profile of Eptacog Beta Confirmed in New Haemophilia Journal Article
European Association of Haemophilia and Allied Disorders (EAHAD) shared and insightful post on X:
”Check the recently published Haemophilia Journal article on Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors. Take a closer look at the data.”
Read the full article here.
Article: Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors
Authors: Manuel Carcao, Cédric Hermans, Adam Giermasz, Craig Kessler, Wolfgang Miesbach, Doris Quon, Jerzy Windyga, Johnny Mahlangu
Stay updated on the latest scientific advances in the field of Hemophilia with Hemostasis Today.
-
Jan 7, 2026, 13:57Joshua Muia: Delighted to Welcome X. Long Zheng for a Versiti Seminar on TTP
-
Jan 7, 2026, 13:40Marilena Vrana Invites You to IPPC2026
-
Jan 7, 2026, 13:32Carlos Villa Joins Versiti Blood Research Institute
-
Jan 7, 2026, 13:21Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25